Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

Background The benefits of pulmonary valve replacement (PVR) for pulmonary insufficiency
in patients with repaired tetralogy of Fallot are still incompletely understood, and optimal …

Aims The role of cardiopulmonary exercise testing (CPET) in predicting major adverse
cardiovascular events (MACE) in people with congenital heart disease (ConHD) is …

Background: Risk factors for adverse clinical outcomes have been identified in patients with
repaired tetralogy of Fallot before pulmonary valve replacement (PVR). However, pre-PVR …

Background The impact of pulmonary valve replacement (PVR) on major adverse clinical
outcomes in patients with repaired tetralogy of Fallot (rTOF) is unknown. Objectives The …

Objectives This study sought to identify patients with repaired tetralogy of Fallot (rTOF) at
high risk of death and malignant ventricular arrhythmia (VA). Background To date there is no …

Background: Pulmonary valve replacement (PVR) in patients with repaired tetralogy of Fallot
provides symptomatic benefit and right ventricular (RV) volume reduction. However, data on …

Background Although QRS duration> 180 ms has prognostic value in adults with tetralogy of
Fallot (TOF), its sensitivity to predict mortality is low. Fragmented QRS complexes, a simple …

Background: Adults with repaired tetralogy of Fallot die prematurely from ventricular
tachycardia (VT) and sudden cardiac death. Inducible VT predicts mortality. Ventricular scar …

Background Adult congenital heart disease (ACHD) guidelines advise life-long, regular,
follow up in predefined intervals for ACHD patients. However, limited data exist to support …